FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aflibercept Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing vinblastine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing vinblastine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinblastine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only vinblastine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vinblastine sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vinblastine sulfate 10 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vismodegib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only vismodegib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing vismodegib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vismodegib 150 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing vismodegib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely alectinib (as alectinib hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing alectinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alectinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vorinostat Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only vorinostat in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing vorinostat Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vorinostat 100 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing vorinostat in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nintedanib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nintedanib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nintedanib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nintedanib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nintedanib (as nintedanib esilate) 100 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nilotinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nilotinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nilotinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nilotinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing paclitaxel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only paclitaxel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely paclitaxel 6 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely paclitaxel 100 milligram/1 vial powder for conventional release suspension for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dabrafenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dabrafenib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dabrafenib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dabrafenib (as dabrafenib mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dabrafenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cabazitaxel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cabazitaxel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cabazitaxel 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cabazitaxel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabazitaxel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dactinomycin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dactinomycin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dactinomycin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dactinomycin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing docetaxel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing docetaxel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only docetaxel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dacarbazine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dacarbazine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dacarbazine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacarbazine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bleomycin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bleomycin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bleomycin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bleomycin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bevacizumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bevacizumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bevacizumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bevacizumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bexarotene in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bexarotene Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bexarotene in cutaneous dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bexarotene in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bexarotene in cutaneous dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bexarotene Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bendamustine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bendamustine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bendamustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bendamustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Everolimus Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only everolimus in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing everolimus Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely everolimus 5 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely everolimus 10 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing everolimus in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing etoposide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing etoposide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing etoposide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only etoposide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only etoposide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Etoposide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely etoposide (as etoposide phosphate) 100 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely etoposide 50 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 4 of 26 Next End

This concept is not in any reference sets

Back to Start